South Korea · Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 66.29 billion. The enterprise value is 69.95 billion.
| Market Cap | 66.29B |
| Enterprise Value | 69.95B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Genesem has 13.15 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 13.15M |
| Shares Outstanding | 13.15M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 44.68% |
| Owned by Institutions (%) | n/a |
| Float | 7.28M |
Valuation Ratios
The trailing PE ratio is 29.49 and the forward PE ratio is 11.60.
| PE Ratio | 29.49 |
| Forward PE | 11.60 |
| PS Ratio | 1.15 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 18.51 |
| P/OCF Ratio | 10.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.73, with an EV/FCF ratio of 19.53.
| EV / Earnings | 31.12 |
| EV / Sales | 1.21 |
| EV / EBITDA | 20.73 |
| EV / EBIT | 32.09 |
| EV / FCF | 19.53 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.44 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 5.46 |
| Debt / FCF | 5.14 |
| Interest Coverage | 2.94 |
Financial Efficiency
Return on equity (ROE) is 4.69% and return on invested capital (ROIC) is 2.02%.
| Return on Equity (ROE) | 4.69% |
| Return on Assets (ROA) | 1.61% |
| Return on Invested Capital (ROIC) | 2.02% |
| Return on Capital Employed (ROCE) | 3.93% |
| Revenue Per Employee | 367.88M |
| Profits Per Employee | 14.32M |
| Employee Count | 157 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Genesem has paid 194.91 million in taxes.
| Income Tax | 194.91M |
| Effective Tax Rate | 7.98% |
Stock Price Statistics
The stock price has increased by +15.07% in the last 52 weeks. The beta is 1.23, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +15.07% |
| 50-Day Moving Average | 5,859.07 |
| 200-Day Moving Average | 5,229.33 |
| Relative Strength Index (RSI) | 39.65 |
| Average Volume (20 Days) | 166,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 57.76 billion and earned 2.25 billion in profits. Earnings per share was 170.89.
| Revenue | 57.76B |
| Gross Profit | 20.65B |
| Operating Income | 2.18B |
| Pretax Income | 2.44B |
| Net Income | 2.25B |
| EBITDA | 3.37B |
| EBIT | 2.18B |
| Earnings Per Share (EPS) | 170.89 |
Balance Sheet
The company has 14.65 billion in cash and 18.42 billion in debt, giving a net cash position of -3.77 billion or -286.45 per share.
| Cash & Cash Equivalents | 14.65B |
| Total Debt | 18.42B |
| Net Cash | -3.77B |
| Net Cash Per Share | -286.45 |
| Equity (Book Value) | 49.30B |
| Book Value Per Share | 3,756.50 |
| Working Capital | 12.72B |
Cash Flow
In the last 12 months, operating cash flow was 6.19 billion and capital expenditures -2.61 billion, giving a free cash flow of 3.58 billion.
| Operating Cash Flow | 6.19B |
| Capital Expenditures | -2.61B |
| Free Cash Flow | 3.58B |
| FCF Per Share | 272.27 |
Margins
Gross margin is 35.76%, with operating and profit margins of 3.77% and 3.89%.
| Gross Margin | 35.76% |
| Operating Margin | 3.77% |
| Pretax Margin | 4.23% |
| Profit Margin | 3.89% |
| EBITDA Margin | 5.84% |
| EBIT Margin | 3.77% |
| FCF Margin | 6.20% |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 73.15% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.98% |
| Earnings Yield | 3.39% |
| FCF Yield | 5.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 2025. It was a forward split with a ratio of 1.5.
| Last Split Date | Nov 24, 2025 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Genesem has an Altman Z-Score of 2.44 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 6 |